Structure-guided GPCR drug development of human single domain camelid antibodies (Nanobody) for autosomal dominant retinitis pigmentosa
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined